These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26476241)

  • 21. Covalent immobilization of porcine pancreatic lipase on carboxyl-activated magnetic nanoparticles: characterization and application for enzymatic inhibition assays.
    Zhu YT; Ren XY; Liu YM; Wei Y; Qing LS; Liao X
    Mater Sci Eng C Mater Biol Appl; 2014 May; 38():278-85. PubMed ID: 24656379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
    Xie Z; Gong H; Liu M; Zhu H; Sun H
    J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymer-Coated Hollow Mesoporous Silica Nanoparticles for Triple-Responsive Drug Delivery.
    Zhang Y; Ang CY; Li M; Tan SY; Qu Q; Luo Z; Zhao Y
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18179-87. PubMed ID: 26221866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase behavior of poly(sulfobetaine methacrylate)-grafted silica nanoparticles and their stability in protein solutions.
    Dong Z; Mao J; Yang M; Wang D; Bo S; Ji X
    Langmuir; 2011 Dec; 27(24):15282-91. PubMed ID: 22124164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Heterogeneous expression of chitinase gene from Bcillus licheniformis MY75 and the characterization of expressed ChiMY].
    Xiao L; Liu C; Xie C; Cai J; Liu D; Chen Y
    Wei Sheng Wu Xue Bao; 2010 Jun; 50(6):749-54. PubMed ID: 20687339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
    Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
    Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
    J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silica-encapsulated magnetic nanoparticles: enzyme immobilization and cytotoxic study.
    Ashtari K; Khajeh K; Fasihi J; Ashtari P; Ramazani A; Vali H
    Int J Biol Macromol; 2012 May; 50(4):1063-9. PubMed ID: 22269345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pH and thermo dual-stimuli-responsive drug carrier based on mesoporous silica nanoparticles encapsulated in a copolymer-lipid bilayer.
    Wu X; Wang Z; Zhu D; Zong S; Yang L; Zhong Y; Cui Y
    ACS Appl Mater Interfaces; 2013 Nov; 5(21):10895-903. PubMed ID: 24127854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chitinase of Bacillus thuringiensis].
    Chigaleĭchik AG
    Mikrobiologiia; 1976; 45(6):966-72. PubMed ID: 13274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large pore mesoporous silica nanomaterials for application in delivery of biomolecules.
    Knežević NŽ; Durand JO
    Nanoscale; 2015 Feb; 7(6):2199-209. PubMed ID: 25583539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of Bacillus thuringiensis Cry6A on the survival, growth, reproduction, locomotion, and behavioral response of Caenorhabditis elegans.
    Luo H; Xiong J; Zhou Q; Xia L; Yu Z
    Appl Microbiol Biotechnol; 2013 Dec; 97(23):10135-42. PubMed ID: 24100681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
    Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
    Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fabrication of porous hollow silica nanoparticles and their applications in drug release control.
    Li ZZ; Wen LX; Shao L; Chen JF
    J Control Release; 2004 Aug; 98(2):245-54. PubMed ID: 15262416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X; Wang Y; Peng B
    Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigations on nanoconfinement of low-molecular antineoplastic agents into biocompatible magnetic matrices for drug targeting.
    Tomoiaga AM; Cioroiu BI; Nica V; Vasile A
    Colloids Surf B Biointerfaces; 2013 Nov; 111():52-9. PubMed ID: 23777792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrostatically controlled swelling and adsorption of polyelectrolyte brush-grafted nanoparticles to the solid/liquid interface.
    Riley JK; Matyjaszewski K; Tilton RD
    Langmuir; 2014 Apr; 30(14):4056-65. PubMed ID: 24660872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multifunctional Mesoporous Silica Nanoparticles Based on Charge-Reversal Plug-Gate Nanovalves and Acid-Decomposable ZnO Quantum Dots for Intracellular Drug Delivery.
    Zhang J; Wu D; Li MF; Feng J
    ACS Appl Mater Interfaces; 2015 Dec; 7(48):26666-73. PubMed ID: 26553405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacillus thuringiensis fermentation of wastewater and wastewater sludge--presence and characterization of chitinases.
    Brar SK; Verma M; Tyagi RD; Valéro JR; Surampalli RY
    Environ Technol; 2008 Feb; 29(2):161-70. PubMed ID: 18613615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyaluronan degrading silica nanoparticles for skin cancer therapy.
    Scodeller P; Catalano PN; Salguero N; Duran H; Wolosiuk A; Soler-Illia GJ
    Nanoscale; 2013 Oct; 5(20):9690-8. PubMed ID: 23969526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.